S&P 500   4,967.23 (-0.88%)
DOW   37,986.40 (+0.56%)
QQQ   414.65 (-2.07%)
AAPL   165.00 (-1.22%)
MSFT   399.12 (-1.27%)
META   481.07 (-4.13%)
GOOGL   154.09 (-1.23%)
AMZN   174.63 (-2.56%)
TSLA   147.05 (-1.92%)
NVDA   762.00 (-10.00%)
AMD   146.64 (-5.44%)
NIO   3.80 (-5.00%)
BABA   69.07 (+0.28%)
T   16.51 (+1.10%)
F   12.14 (+0.66%)
MU   106.77 (-4.61%)
GE   148.06 (-3.19%)
CGC   7.93 (+1.28%)
DIS   112.61 (+0.16%)
AMC   3.16 (+8.22%)
PFE   26.00 (+2.40%)
PYPL   62.31 (+0.34%)
XOM   119.88 (+1.15%)
S&P 500   4,967.23 (-0.88%)
DOW   37,986.40 (+0.56%)
QQQ   414.65 (-2.07%)
AAPL   165.00 (-1.22%)
MSFT   399.12 (-1.27%)
META   481.07 (-4.13%)
GOOGL   154.09 (-1.23%)
AMZN   174.63 (-2.56%)
TSLA   147.05 (-1.92%)
NVDA   762.00 (-10.00%)
AMD   146.64 (-5.44%)
NIO   3.80 (-5.00%)
BABA   69.07 (+0.28%)
T   16.51 (+1.10%)
F   12.14 (+0.66%)
MU   106.77 (-4.61%)
GE   148.06 (-3.19%)
CGC   7.93 (+1.28%)
DIS   112.61 (+0.16%)
AMC   3.16 (+8.22%)
PFE   26.00 (+2.40%)
PYPL   62.31 (+0.34%)
XOM   119.88 (+1.15%)
S&P 500   4,967.23 (-0.88%)
DOW   37,986.40 (+0.56%)
QQQ   414.65 (-2.07%)
AAPL   165.00 (-1.22%)
MSFT   399.12 (-1.27%)
META   481.07 (-4.13%)
GOOGL   154.09 (-1.23%)
AMZN   174.63 (-2.56%)
TSLA   147.05 (-1.92%)
NVDA   762.00 (-10.00%)
AMD   146.64 (-5.44%)
NIO   3.80 (-5.00%)
BABA   69.07 (+0.28%)
T   16.51 (+1.10%)
F   12.14 (+0.66%)
MU   106.77 (-4.61%)
GE   148.06 (-3.19%)
CGC   7.93 (+1.28%)
DIS   112.61 (+0.16%)
AMC   3.16 (+8.22%)
PFE   26.00 (+2.40%)
PYPL   62.31 (+0.34%)
XOM   119.88 (+1.15%)
S&P 500   4,967.23 (-0.88%)
DOW   37,986.40 (+0.56%)
QQQ   414.65 (-2.07%)
AAPL   165.00 (-1.22%)
MSFT   399.12 (-1.27%)
META   481.07 (-4.13%)
GOOGL   154.09 (-1.23%)
AMZN   174.63 (-2.56%)
TSLA   147.05 (-1.92%)
NVDA   762.00 (-10.00%)
AMD   146.64 (-5.44%)
NIO   3.80 (-5.00%)
BABA   69.07 (+0.28%)
T   16.51 (+1.10%)
F   12.14 (+0.66%)
MU   106.77 (-4.61%)
GE   148.06 (-3.19%)
CGC   7.93 (+1.28%)
DIS   112.61 (+0.16%)
AMC   3.16 (+8.22%)
PFE   26.00 (+2.40%)
PYPL   62.31 (+0.34%)
XOM   119.88 (+1.15%)
Free Trial
ASX:MYX

Mayne Pharma Group (MYX) Stock Price, News & Analysis

→ SHOCKING Crypto Leak… (From Crypto 101 Media) (Ad)
Free MYX Stock Alerts
Compare
Today's Range
N/A
50-Day Range
N/A
52-Week Range
N/A
Volume
5.47 million shs
Average Volume
N/A
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
0.84%
Price Target
N/A
Stock Analysis
Stock Analysis
MYX stock logo

About Mayne Pharma Group Stock (ASX:MYX)

Mayne Pharma Group Limited, a specialty pharmaceutical company, manufactures and sells branded and generic pharmaceutical products in Australia, New Zealand, the United States, Canada, Europe, Asia, and internationally. The company operates through four segments: International Branded Products, and Portfolio Product Division. It provides oral drug delivery systems; and contract development and manufacturing services to third-party customers, as well as distributes specialty pharmaceutical products in the dermatology, women's health, and infectious disease therapeutic areas. The company was formerly known as Halcygen Pharmaceuticals Limited and changed its name to Mayne Pharma Group Limited in November 2010. Mayne Pharma Group Limited was incorporated in 2005 and is based in Salisbury South, Australia.

MYX Stock News Headlines

March 31, 2024 | finance.yahoo.com
Investors in Mayne Pharma Group (ASX:MYX) have seen respectable returns of 93% over the past year
February 21, 2024 | investing.com
Mayne Pharma Group Ltd (MYX)
April 19, 2024 | Behind the Markets (Ad)
Tiny Biotech Stock Wins $75 Billion Patent
A little-known biotech has been quietly working on revolutionary treatments for neurodegenerative diseases. Most people have never heard of them... but those in the know have been taking notice. Jeff Bezos cut them a check for $130 million. Fidelity Biosciences for a further $217 million. They've even had several collaborative partnerships with much larger companies like Biogen, Sanofi, and Takeda.
February 15, 2024 | uk.finance.yahoo.com
Mithra sells shares in Mayne Pharma
February 15, 2024 | finanznachrichten.de
Mithra Pharmaceuticals: Mithra sells shares in Mayne Pharma
February 15, 2024 | wsj.com
Mayne Pharma Group Ltd.
December 2, 2023 | morningstar.com
Mayne Pharma Group Ltd MYX
September 27, 2023 | finance.yahoo.com
How much Novan sold its assets for in bankruptcy case
April 19, 2024 | Behind the Markets (Ad)
Tiny Biotech Stock Wins $75 Billion Patent
A little-known biotech has been quietly working on revolutionary treatments for neurodegenerative diseases. Most people have never heard of them... but those in the know have been taking notice. Jeff Bezos cut them a check for $130 million. Fidelity Biosciences for a further $217 million. They've even had several collaborative partnerships with much larger companies like Biogen, Sanofi, and Takeda.
September 11, 2023 | uk.finance.yahoo.com
Mayne Pharma Group Limited (HG6.F)
August 31, 2023 | fool.com.au
Guess which ASX 300 healthcare stock just tanked 20%
June 8, 2023 | msn.com
WILSONS Upgrades Mayne Pharma Group (ASX:MYX)
June 8, 2023 | finance.yahoo.com
Retail investors account for 50% of Mayne Pharma Group Limited's (ASX:MYX) ownership, while institutions account for 19%
June 1, 2023 | msn.com
Mayne Pharma Group (ASX:MYX) Price Target Increased by 7.69% to 4.43
May 15, 2023 | finance.yahoo.com
Mayne Pharma Group (ASX:MYX shareholders incur further losses as stock declines 13% this week, taking five-year losses to 72%
March 30, 2023 | msn.com
Multiple directors are buying this beaten-up ASX 300 healthcare stock
March 28, 2023 | finance.yahoo.com
Frank Condella Is The Independent Non-Executive Chairman of Mayne Pharma Group Limited (ASX:MYX) And They Just Picked Up 56% More Shares
March 1, 2023 | finanznachrichten.de
Dr. Reddy's Laboratories Ltd.: Dr. Reddy's Laboratories Announces Agreement to Acquire Mayne Pharma's U.S. Generic Prescription Product Portfolio
March 1, 2023 | seekingalpha.com
Dr. Reddy's to acquire U.S. generic portfolio of Mayne Pharma
March 1, 2023 | msn.com
Guess which ASX 300 share has rocketed 27% in 2 days since reporting
January 16, 2023 | fool.com.au
CRASH! Why Mayne Pharma Group Ltd’s share price plunged 22% today
January 2, 2023 | fool.com.au
Is the Mayne Pharma Group Ltd share price too cheap to ignore?
December 29, 2022 | finance.yahoo.com
Mayne Pharma Group Limited (ASX:MYX) most popular amongst individual investors who own 56% of the shares, institutions hold 20%
November 30, 2022 | fool.com.au
Why is this ASX All Ords share crashing 27% today?
August 21, 2022 | fool.com.au
Mayne Pharma Group Ltd doubles sales: Is it a buy?
August 10, 2022 | fool.com.au
Mayne Pharma share price rockets 25% on $680 million payday
August 10, 2022 | nasdaq.com
Catalent To Acquire Metrics Contract Services From Mayne Pharma For $475 Mln
See More Headlines
Receive MYX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Mayne Pharma Group and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
2/22/2019
Today
4/19/2024
Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange
ASX
Sector
Medical
Industry
Drug Manufacturers - General
Sub-Industry
N/A
Current Symbol
ASX:MYX
CUSIP
N/A
CIK
N/A
Web
www.maynepharma.com
Phone
+61-8-82092666
Fax
N/A
Employees
780
Year Founded
N/A

Profitability

EPS (Most Recent Fiscal Year)
A($3.18)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
0.51
Net Income
$-274,180,000.00
Net Margins
-76.21%
Pretax Margin
N/A
Return on Equity
-40.74%
Return on Assets
-5.46%

Debt

Debt-to-Equity Ratio
6.68
Current Ratio
1.61
Quick Ratio
0.62

Sales & Book Value

Annual Sales
$319.28 million
Price / Sales
0.00
Cash Flow
N/A
Price / Cash Flow
7.20
Book Value
A$6.74 per share
Price / Book
N/A

Miscellaneous

Outstanding Shares
85,070,000
Free Float
N/A
Market Cap
N/A
Optionable
Not Optionable
Beta
1.31
7 AI Stocks to Invest In: An Introduction to AI Investing For Self-Directed Investors Cover
7 AI Stocks to Invest In: An Introduction to AI Investing For Self-Directed Investors

As the AI market heats up, investors who have a vision for artificial intelligence have the potential to see real returns. Learn about the industry as a whole as well as seven companies that are getting work done with the power of AI.

Get This Free Report

Key Executives

  • Mr. Shawn Patrick O'Brien B.Sc (Age 65)
    CEO, MD & Director
    Comp: $1.27M
  • Mr. Aaron Gray
    Chief Financial Officer
  • Ms. Kimberly Parker J.D.
    Executive VP & General Counsel
  • Mr. Brant Schofield (Age 58)
    Executive Vice President of Corporate Development
    Comp: $1.04M
  • Ms. Erinn Nathaniel
    Director of Global Human Resources
  • Mr. Daniel Moore
    Executive Vice President of Commercial
  • Dr. Frank Casty M.D.
    Executive VP & Global Chief Medical Officer
  • Mr. Brenton Walter
    Financial Controller
  • Ms. Laura Loftus
    Associate General Counsel & Company Secretary

Key Competitors

View All Competitors

Insiders


MYX Stock Analysis - Frequently Asked Questions

How were Mayne Pharma Group's earnings last quarter?

Mayne Pharma Group Limited (ASX:MYX) announced its earnings results on Friday, February, 22nd. The company reported $0.02 earnings per share (EPS) for the quarter. Mayne Pharma Group had a negative net margin of 76.21% and a negative trailing twelve-month return on equity of 40.74%.

Is Mayne Pharma Group a good dividend stock?

Mayne Pharma Group (ASX:MYX) pays an annual dividend of A$0.04 per share and currently has a dividend yield of 0.84%.

What other stocks do shareholders of Mayne Pharma Group own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Mayne Pharma Group investors own include Sundance Energy (SNDE), Turquoise Hill Resources (TRQ), Telstra Group (TLS), Green Organic Dutchman (TGODF), Perseus Mining (PRU), Organigram (OGI), Karoon Energy (KAR), Crown Resorts (CWN) and Cronos Group (CRON).

This page (ASX:MYX) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners
The “Perfect Storm” for Gold
Gold Safe Exchange
Tiny Biotech Stock Wins $75 Billion Patent
Behind the Markets
Biden’s $374B Giveaway Into This Sector
DTI
He Is Giving Away Bitcoin
Crypto Swap Profits
SHOCKING Crypto Leak…
Crypto 101 Media
Don’t Miss Out on the AI Gold Rush That’s Just Getting Started
Banyan Hill Publishing
How Biden has already won 2024
Porter & Company
Urgent alert: open this for a huge profit potential
Timothy Sykes